Indaptus Therapeutics (INDP) Insider Trading & Ownership $0.47 +0.01 (+2.17%) Closing price 05/1/2025 03:59 PM EasternExtended Trading$0.48 +0.01 (+2.98%) As of 05/1/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Indaptus Therapeutics (NASDAQ:INDP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage29.50%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$243,983.73Number OfInsiders Selling(Last 3 Years)0 Get INDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INDP Insider Buying and Selling by Quarter Indaptus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2023Glen R AndersonMajor ShareholderBuy23,934$2.34$56,005.56 8/10/2023Glen R AndersonMajor ShareholderBuy44,354$1.94$86,046.76 12/1/2022Boyan Vesselinov LitchevInsiderBuy500$1.87$935.00 11/22/2022Boyan Vesselinov LitchevInsiderBuy500$1.83$915.00 11/21/2022Jeffrey A MecklerCEOBuy9,600$1.90$18,240.00 11/18/2022Jeffrey A MecklerCEOBuy400$1.76$704.00 9/8/2022Jeffrey A MecklerCEOBuy10,308$2.80$28,862.40 9/7/2022Walt Addison LinscottInsiderBuy150$2.62$393.00 6/6/2022Jeffrey A MecklerCEOBuy19,727$2.63$51,882.01 (Data available from 1/1/2013 forward) INDP Insider Trading Activity - Frequently Asked Questions Who is on Indaptus Therapeutics's Insider Roster? The list of insiders at Indaptus Therapeutics includes Boyan Vesselinov Litchev, Glen R Anderson, Jeffrey A Meckler, and Walt Addison Linscott. Learn more on insiders at INDP. What percentage of Indaptus Therapeutics stock is owned by insiders? 29.50% of Indaptus Therapeutics stock is owned by insiders. Learn more on INDP's insider holdings. Which Indaptus Therapeutics insiders have been buying company stock? The following insider purchased INDP shares in the last 24 months: Glen R Anderson ($142,052.32). How much insider buying is happening at Indaptus Therapeutics? Insiders have purchased a total of 68,288 INDP shares in the last 24 months for a total of $142,052.32 bought. Indaptus Therapeutics Key ExecutivesMr. Jeffrey A. Meckler (Age 57)CEO & Director Compensation: $867.03kDr. Michael J. Newman Ph.D. (Age 68)Founder, Chief Scientific Officer & Director Compensation: $659.99kMr. Walt Addison Linscott Esq. (Age 63)Chief Operating Officer Compensation: $716.35kMr. Nir Sassi (Age 48)CFO, Secretary & Treasurer Compensation: $378.47kDr. Roger J. Waltzman M.B.A. (Age 56)M.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Clene Insider Transactions Tempest Therapeutics Insider Transactions Q32 Bio Insider Transactions Lexaria Bioscience Insider Transactions Cara Therapeutics Insider Transactions Cyclo Therapeutics Insider Transactions CASI Pharmaceuticals Insider Transactions Eagle Pharmaceuticals Insider Transactions DURECT Insider Transactions Synergy CHC Corp. (Uplisting) Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:INDP) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.